Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

Poster session 04

1284P - Lung cancer among patients with chronic obstructive pulmonary disease: A Danish 10-year observational study of the overlapping population


21 Oct 2023


Poster session 04


Population Risk Factor;  Cancer Registries;  Secondary Prevention/Screening;  Cancer Diagnostics;  Cancer Research

Tumour Site

Small Cell Lung Cancer;  Non-Small Cell Lung Cancer


Margrethe Henriksen


Annals of Oncology (2023) 34 (suppl_2): S732-S745. 10.1016/annonc/annonc1304


M.B. Henriksen1, L.H. Jensen2, O. Hilberg3, T.F. Hansen4, C.L. Brasen5

Author affiliations

  • 1 Department Of Oncology, Vejle University Hospital, 7100 - Vejle/DK
  • 2 Department Of Oncology, Danish Colorectal Cancer Center South, University Hospital of Southern Denmark, Vejle Hospital, 7100 - Vejle/DK
  • 3 Department Of Internal Medicine, Sygehus Lillebaelt - Vejle Sygehus, 7100 - Vejle/DK
  • 4 Oncology, Vejle Hospital, University of Southern Denmark, 5000 - Odense/DK
  • 5 Department Og Immunology And Biochemistry, Vejle Hospital, University Hospital of Southern Denmark, 7000 - Vejle/DK


Login to access the resources on OncologyPRO.

If you do not have an ESMO account, please create one for free.

Abstract 1284P


Lung cancer (LC) is the leading cause of cancer-related death worldwide, and up to five times more likely to occur in smokers with chronic obstructive pulmonary disease (COPD) than those with normal lung function. In this study, we investigated the overlap between patients registered with COPD and patients examined on suspicion of LC over a 10-year period in the Region of Southern Denmark.


The National Registry of COPD and the Danish LC Registry delivered data on patients with COPD and LC respectively. The cohort referred for LC diagnostics was defined by assigned classification codes provided from the Health Care Classification System.


During the study period, 25,647 patients were registered with COPD during hospitalizations, or from outpatient clinics. Among these, 5.030 patients (20%) were referred to LC diagnostics, and 1,551 were diagnosed with LC. This corresponds to a LC incidence of 6% among all patients with COPD, and 31% among COPD patients referred for LC diagnostics. COPD patients referred for LC diagnostics were generally more affected by COPD compared to the group of not referred for LC diagnostics. Referred patients collected more COPD related medication (6 of 7 medicaments), performed worse in terms of lung function (FEV1% 48% vs. 50%), suffered from a higher grade of dyspnea (71% vs. 57% MRC 3-5) and experiences a higher rate of exacerbations (42% vs. 31% with 2-3 exacerbations) compared to COPD patients not referred to LC diagnostics (p<0.05 for all). Among all patients who underwent LC diagnostics, COPD patients displayed a higher prevalence of LC compared to the non-COPD patients (31% vs. 29%, p<0.005). LC patients with COPD were more likely to be stage I-II compared to the non-COPD LC population (39% vs. 24%, p<0.05).


This study reveals a substantial overlap between patients with COPD and patients undergoing LC diagnostics (20%). It suggests that patients more affected by COPD are more likely to undergo LC diagnostics, and LC patients with COPD are more likely to be diagnosed in early stages. It underlines the overrepresentation of LC patients among patients with COPD, and emphasizes the need to address these patients specifically once initiating a screening program.

Clinical trial identification

Editorial acknowledgement

Legal entity responsible for the study

Margrethe Bang Henriksen.


Has not received any funding.


All authors have declared no conflicts of interest.

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings
  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.